SKB565 injection for advanced solid cancers
Part of Cancer clinical trials.
This study tests SKB565, a new injectable cancer treatment, in people with advanced solid tumors (cancer that has spread or hasn't responded to standard treatments). The trial aims to find the right dose and learn how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced solid cancer that has failed standard treatment, has no standard treatment available, or you couldn't tolerate standard treatment
- Your cancer can be measured on imaging scans (at least one lesion visible)
- You are able to perform light daily activities with minimal assistance (ECOG score 0 or 1)
- Your bone marrow, liver, kidney, and blood clotting functions are adequate
- You are expected to live at least 12 weeks
- You agree to use effective birth control during the study if you can become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SKB105 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective.
This trial tests a new drug called SKB518 for people with advanced solid tumors that have stopped responding to standard treatments or cannot receive them. The goal is to see if SKB518 can help shrink or control the tumor.
This study tests a new drug called SKB118 for advanced solid cancers (any cancer that has spread) that have not responded to standard treatments. The drug is designed to help the immune system fight cancer cells.
This trial tests a new drug called SKB445 for people with advanced solid tumors that have stopped responding to other treatments. The goal is to see if the drug is safe and effective for these patients.
This trial tests a new drug called SKB500 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and may help shrink tumors.
This trial tests a new drug called SKB103 for people with advanced solid tumors that have not responded to standard treatments or who cannot tolerate them. The study aims to see if SKB103 is safe and effective.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.